Frazier Healthcare has completed its acquisition of the Onsite Services instrument management and repair business of publicly traded CareFusion. Financial terms of the deal were not released. OnSite Services delivers education-based medical instrument repair and instrument management programs to hospital systems domestically, the company said in a statement. The deal was first announced in January.
CareFusion (NYSE: CFN), a leading, global medical technology company, and Frazier Healthcare today announced they have completed the sale of CareFusion’s OnSite® Services instrument management and repair business to affiliates of Frazier Healthcare.
The companies previously announced plans for the sale on January 11.
OnSite Services delivers education-based medical instrument repair and instrument management programs to hospital systems domestically. The new company and its 240 employees will continue to deliver operating-room focused workflow improvement programs.
Under the terms of an agreement between CareFusion and OnSite Services, OnSite Services will remain the preferred repair organization for CareFusion V. Mueller and Snowden-Pencer® specialty surgical instruments.
Financial terms of the agreement were not disclosed.
CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve patient care. The company develops market-leading technologies including Alaris® infusion pumps, Pyxis® automated dispensing and patient identification systems, AirLife™, AVEA® and LTV® series of ventilators and respiratory products, ChloraPrep® skin prep products, MedMined™ services for data mining surveillance, V. Mueller® and Snowden-Pencer® surgical instruments and NeuroCare diagnostic products. CareFusion employs more than 15,000 people across its global operations. More information may be found at www.carefusion.com.
About Frazier Healthcare
Founded in 1991, Frazier Healthcare is a leading provider of growth equity and venture capital to high growth and emerging health care service, biopharma and medical device companies. With over $1.8 billion under management across seven funds, Frazier Healthcare has invested in over 100 companies across the entire developmental spectrum. From seed stage venture investments to leveraged recapitalizations of cash generating companies, Frazier Healthcare has established itself among entrepreneurs and seasoned executives as a preferred partner to help create and grow successful health care companies.